Picture BIO Deutschland EBDC 2016 Frankfurt 600x60px
Document › Details

4-Antibody AG. (8/16/11). "Press Release: 4-Antibody AG Forms Collaboration with Human Genome Sciences". Basel.

Organisations Organisation 4-Antibody AG
  Group Agenus (Group)
  Organisation 2 Human Genome Sciences (HGSI) (Group)
  Today GlaxoSmithKline (GSK) (Group)
  Group GlaxoSmithKline (GSK) (Group)
Products Product MAb, human, fully
  Product 2 Retrocyte Display® technology
  Index term 2 4-Antibody–College Group: public relations, 201109 service existent by College Hill Life Sciences
Persons Person Burns, Robert F. (4-Antibody 201101– CEO before Affitech CEO before Celldex Therapeutics CEO)
  Person 2 Mayer, Robert (Medigene 201512– Senior Manager PR + IR before College Hill Life Sciences/Northbank Munich)

4-Antibody AG today announced the signing of a collaboration agreement with Human Genome Sciences (HGS) to discover and develop fully human therapeutic antibodies. Financial terms of the deal were not disclosed.

The collaboration with HGS is focused on 4-Antibody's proprietary high throughput in vitro Retrocyte Display® technology for rapid discovery of fully human antibodies against novel targets nominated by HGS. The Retrocyte Display® technology (Retroviral B lymphocyte Display) is a potent and fast tool for high quality therapeutic antibody discovery and optimization using a rapid flow cytometry approach. Full-length immunoglobulin antibody libraries are expressed in mammalian B-lineage cells, the cell designed by nature for optimal antibody display, resulting in 'better-behaved', fully human antibodies. This collaboration agreement, which initially involves two projects, is 4-Antibody's second such alliance with a pharmaceutical partner, the first being with Boehringer Ingelheim which commenced in early 2010.

Dr Robert Burns, 4-Antibody's CEO, said: "We're delighted to announce our second collaboration with an established pharmaceutical partner. Collaborations serve an important role in validating our Retrocyte Display® technology platform and we're delighted that HGS wanted to enter into this Multi-target collaboration with us. This adds an additional momentum to our other ongoing partnering activities."

- ends -

Further Information:

Dr Robert Burns
4-Antibody AG
t: +41-61-633-20-60

Dr Robert Mayer
Account Manager
College Hill
t: +49-89-5238-8030

About 4-Antibody AG

4-Antibody is a biopharmaceutical company with a powerful fully-human antibody drug-discovery technology platform which is generating an emerging pipeline of antibody therapeutics. The proprietary discovery engine is the in vitro Retrocyte Display® technology, a fast and highly efficient source of antibody drug candidates. Retrocyte Display® generates high quality therapeutic antibody drug candidates quickly using a rapid, high-throughput, flow cytometry approach incorporating fulllength IgG format human antibody libraries expressed in mammalian B cells. 4-Antibody provides access to its technologies to select pharmaceutical R&D collaborators and is also generating an inhouse pipeline of antibody drugs. The Company's lead development product is an anticytomegalovirus antibody drug. 4-Antibody is a private company with strong, commerciallyexperienced leadership located in Basel, Switzerland and Jena, Germany.

For more information please visit:

*** 4-Antibody moves to new offices and labs***

Please note the new address and phone number of our Basel operation:
4-Antibody AG
Hochbergerstrasse 60C
CH-4057 Basel, Switzerland
Phone: +41-61-633-20-60

About Human Genome Sciences

Human Genome Sciences exists to place new therapies into the hands of those battling serious disease. For more information about HGS, please visit the Company's web site at .

4-Antibody AG
Hochbergerstrasse 60C
CH-4057 Basel, Switzerland
Phone: +41-61-633-2260

Record changed: 2015-08-01


Picture [LSF] – The Business Web Portal 600x80px

More documents for Agenus (Group)

To subscribe to our free, monthly newsletter for the life sciences in German-speaking Europe (DE, AT & CH), please send an e-mail to and simply fill the subject line with the word »LSG newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at (European life sciences) and (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture [iito] Roadshow Season Spring 2016 JPMorgan Healthcare 2017 600x560px

» top


Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture BIO Deutschland EBDC 2016 Frankfurt 120x240px Picture [iito] Roadshow Spring 2016 Offer 120x180px Picture [LSE] – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px